Pulmonx Corporation LUNG Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's accretion (amortization) of discounts and premiums, investments?
- Pulmonx Corporation (LUNG) reported accretion (amortization) of discounts and premiums, investments of $0 in Q1 2026.
- How has Pulmonx Corporation's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Pulmonx Corporation's accretion (amortization) of discounts and premiums, investments decreased by 100.0% year-over-year, from $206K to $0.
- What is the long-term trend for Pulmonx Corporation's accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), Pulmonx Corporation's accretion (amortization) of discounts and premiums, investments has grown at a 59.2% compound annual growth rate (CAGR), from -$59K to $379K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This metric captures the non-cash adjustment to the carrying value of investment securities to reflect the amortization of premiums or the accretion of discounts over the life of the instrument. It reconciles the difference between the purchase price of a security and its face value, ensuring interest income is recognized effectively over time. This provides insight into the yield profile and accounting treatment of the company's liquid investment portfolio.